Holen Sie sich die Stockscreener-App
7.32
4.42%
0.31
Vorhandelsmarkt:
7.31
-0.01
-0.14%
Schlusskurs vom Vortag:
$7.01
Offen:
$7
24-Stunden-Volumen:
621.05K
Relative Volume:
0.80
Marktkapitalisierung:
$363.88M
Einnahmen:
$1.97B
Nettoeinkommen (Verlust:
$8.60M
KGV:
40.67
EPS:
0.18
Netto-Cashflow:
$60.15M
1W Leistung:
+6.55%
1M Leistung:
+10.91%
6M Leistung:
-27.81%
1J Leistung:
-57.88%
1-Tages-Spanne:
$6.94
$7.38
1-Wochen-Bereich:
$6.77
$7.38
52-Wochen-Spanne:
$5.95
$19.30
Nu Skin Enterprises Inc Stock (NUS) Company Profile
Firmenname
Nu Skin Enterprises Inc
Sektor
Telefon
801-345-1000
Adresse
75 WEST CENTER ST, PROVO, UT
Vergleichen Sie NUS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NUS
Nu Skin Enterprises Inc
|
7.32 | 363.88M | 1.97B | 8.60M | 60.15M | 0.18 |
|
PG
Procter Gamble Co
|
161.72 | 379.90B | 83.91B | 14.32B | 15.85B | 5.80 |
|
UL
Unilever Plc Adr
|
56.91 | 140.75B | 64.93B | 7.15B | 0 | 2.832 |
|
CL
Colgate Palmolive Co
|
88.23 | 72.08B | 20.11B | 2.87B | 3.40B | 3.49 |
|
KMB
Kimberly Clark Corp
|
126.52 | 42.19B | 20.10B | 2.61B | 2.90B | 7.71 |
|
KVUE
Kenvue Inc
|
20.80 | 39.88B | 15.46B | 1.06B | 1.40B | 0.55 |
Nu Skin Enterprises Inc Stock (NUS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-01-31 | Herabstufung | Jefferies | Buy → Hold |
| 2021-02-12 | Herabstufung | DA Davidson | Buy → Neutral |
| 2020-10-02 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2020-07-02 | Hochstufung | DA Davidson | Neutral → Buy |
| 2020-07-02 | Hochstufung | Jefferies | Hold → Buy |
| 2020-03-09 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2019-12-05 | Fortgesetzt | Citigroup | Neutral |
| 2019-11-06 | Herabstufung | Citigroup | Buy → Neutral |
| 2019-10-30 | Hochstufung | Stifel | Sell → Hold |
| 2019-07-17 | Herabstufung | DA Davidson | Buy → Neutral |
| 2019-07-17 | Herabstufung | Jefferies | Buy → Hold |
| 2019-06-19 | Bestätigt | BofA/Merrill | Underperform |
| 2019-05-01 | Bestätigt | BofA/Merrill | Underperform |
| 2019-05-01 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2019-04-12 | Bestätigt | BofA/Merrill | Underperform |
| 2019-03-25 | Herabstufung | Stifel | Hold → Sell |
| 2018-12-06 | Bestätigt | BofA/Merrill | Underperform |
| 2018-10-10 | Eingeleitet | DA Davidson | Buy |
| 2018-08-03 | Hochstufung | Stifel | Sell → Hold |
| 2018-06-14 | Eingeleitet | Jefferies | Buy |
| 2018-02-16 | Bestätigt | Stifel | Sell |
| 2018-01-23 | Bestätigt | Citigroup | Buy |
Alle ansehen
Nu Skin Enterprises Inc Aktie (NUS) Neueste Nachrichten
NUS Q4 Preliminary Revenues Reach Top End of Outlook, Stock Gains 9.8% - MSN
What Does Nu Skin's Mavely Sale Mean for Its Long-Term Strategy? - MSN
Nu Skin Enterprises rises 4.3%, sells Mavely platform for $250 million - MSN
Barclays PLC Raises Stake in Nu Skin Enterprises, Inc. (NYSE:NUS) - MarketBeat
Nu Skin hits Q4 revenue target, to present at ICR Conference - Investing.com Canada
Nu Skin (NUS) Surges on Strong Guidance and Strategic Updates - GuruFocus.com
Nu Skin rallies after favorable guidance update - MSN
Nu Skin hits Q4 revenue target, to present at ICR Conference By Investing.com - Investing.com South Africa
Nu Skin Enterprises (NYSE:NUS) Releases Q4 2024 Earnings Guidance - MarketBeat
Nu Skin Enterprises Announces Q4 Preliminary Revenue at High End of Guidance - Business Wire
Institutional owners may take dramatic actions as Nu Skin Enterprises, Inc.'s (NYSE:NUS) recent 17% drop adds to one-year losses - Simply Wall St
Nu Skin: New Cash From Mavely's Sale Could Accelerate Inorganic Growth (NYSE:NUS) - Seeking Alpha
Nu Skin Enterprises jumps on a deal to sell its Mavely marketing tech platform - MSN
Nu Skin Enterprises announces strategic transaction of Mavely for $250M - Utah Business
Nu Skin Enterprises (NUS) Stock Dips Amid Market Volatility - GuruFocus.com
Nu Skin Sells Its Mavely Amidst Industry Competition - GuruFocus.com
Later Acquires Mavely for $250 Million, Unlocking New Opportunities for Marketers and Creators to Maximize their Return on Social - Marketscreener.com
Nu Skin Sells Mavely Platform to Later for $250M - Yahoo Finance
Nu Skin unit sells Mavely platform to Later for $250 million - Investing.com Nigeria
Nu Skin’s Rhyz Sells Mavely in $250 Million Strategic Transaction - Direct Selling News
Nu Skin’s Rhyz completes sale of Mavely for $250M - MSN
Nu Skin (NUS) Soars on Sale of Mavely Platform - GuruFocus.com
Nu Skin (NUS) Up 17% at Pre-Market Trade After Raising $250M Fresh Funds - MSN
Nu Skin (NUS) Shares Skyrocket, What You Need To Know - Yahoo Finance
Nu Skin Enterprises jumps on a deal to sell its Mavely marketing technology platfo - Investing.com India
Nu Skin Enterprises’ Rhyz Sells Mavely Affiliate to Portfolio Company Later in $250 Million Cash Deal - Happi
Why Is Nu Skin Enterprises Stock Jumping Today? - Benzinga
Nu Skin Shares Rise Premarket on Sale of Mavely Platform - MarketWatch
Nu Skin Enterprises rallies, sells Mavely platform for $250 million (NYSE:NUS) - Seeking Alpha
Finanzdaten der Nu Skin Enterprises Inc-Aktie (NUS)
Umsatz
Nettogewinn
Free Cashflow
ENV
7.04%
6.66%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):